Clinical trial evaluating the safety, tolerability, and preliminary efficacy of BNT116 alone and in combinations in patients with advanced non-small cell lung cancer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-509283-14-00

Acronym

BNT116-01

Enrollment

123

Registered

2024-02-01

Start date

2022-04-25

Completion date

Unknown

Last updated

2025-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced non-small cell lung cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany, Hungary, Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026